What is the management approach for an adult patient with a periampullary mass showing benign histopathologic findings of duodenal mucosa with villi and Brunner glands?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Periampullary Mass with Benign Brunner Gland Histology

For a periampullary mass showing only benign duodenal mucosa with villi and Brunner glands on histopathology, resection is generally unnecessary unless the lesion is symptomatic, large (>2 cm), or causing complications such as bleeding or obstruction. 1

Understanding the Pathology

Brunner gland hamartomas are uncommon, benign lesions arising from lobular proliferation of normal duodenal Brunner glands. 1 These lesions:

  • Are typically solitary and pedunculated, potentially reaching 2-5 cm in size 1
  • Represent non-neoplastic proliferations without malignant potential in the vast majority of cases 1, 2
  • Can mimic neoplastic adenomatous pathology on endoscopic appearance, requiring careful optical evaluation and pathologic inspection 1

Clinical Decision Algorithm

Asymptomatic Lesions ≤2 cm

  • No intervention required - observation is appropriate 1, 2
  • Document the lesion's relationship to the major and minor papilla with photodocumentation to ensure no papillary involvement 1
  • Confirm benign histology shows no dysplasia (rare cases of dysplasia have been reported) 2, 3

Symptomatic Lesions or Size >2 cm

Consider endoscopic or surgical resection if the lesion causes: 1, 2

  • Partial duodenal obstruction 1, 3, 4
  • Gastrointestinal bleeding or melena 3, 5, 6
  • Abdominal pain related to the mass 3, 4
  • Biliary or pancreatic duct obstruction (rare but reported) 4

Resection Approach Based on Size and Location

  • Pedunculated lesions: May be amenable to endoscopic polypectomy 7, 6
  • Large sessile lesions (>5 cm): Often require surgical resection via transduodenal polypectomy or segmental duodenal resection 3, 4
  • Periampullary location: Requires careful assessment to avoid ampullary injury; may necessitate surgical rather than endoscopic approach 4

Critical Pitfalls to Avoid

Biopsy-induced complications: While diagnostic biopsy confirmed benign histology in this case, be aware that biopsy can induce submucosal scarring that complicates subsequent endoscopic resection if later needed. 8

Bleeding risk: The duodenal location carries higher post-procedural bleeding risk than other GI sites, with risk proportional to lesion size (>25% for lesions >3 cm). 1, 2 For large symptomatic lesions requiring resection, patients should be counseled about this risk and monitored for 48 hours post-procedure. 1

Misdiagnosis of malignancy: Large Brunner gland lesions can mimic pancreatic or periampullary malignancy on imaging, potentially leading to unnecessary pancreaticoduodenectomy. 4 Endoscopic evaluation combined with endoscopic ultrasound helps establish the correct diagnosis and avoid overtreatment. 4

Incomplete histologic sampling: Ensure adequate tissue sampling, as superficial biopsies may miss deeper pathology. 7 However, in this case with confirmed benign Brunner gland histology showing normal duodenal architecture, malignancy is effectively excluded.

Follow-Up Recommendations

  • For observed lesions: No specific surveillance protocol is established for benign Brunner gland lesions, but repeat endoscopy may be considered if symptoms develop 5
  • After resection: Endoscopic surveillance to monitor for recurrence, though recurrence of truly benign Brunner gland lesions is uncommon 7, 5
  • Acid suppression: Consider H2 antagonists or proton pump inhibitors as adjunctive therapy, as hyperacidity may contribute to Brunner gland hyperplasia 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Bile Reflux Gastritis with Duodenal Bulb Lesion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Brunner's gland hyperplasia.

The American surgeon, 1989

Research

Large Brunner's gland adenoma: case report and literature review.

World journal of gastroenterology, 2006

Guideline

Diagnostic Approach to D1 Duodenal Tumors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.